A drug resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient

Revista Latinoamericana de Microbiologia

Volumn 48, Issue 3-4, 2006, Pages 256-259

  Ivette, Lopez Roa Rocio ^a   Mary, Fafutis Morris ^a   Masanori, Matsuoka ^b  

^a INSTITUTO DERMATOLÓGICO DE JALISCO DR JOSÉ BARBA RUBIO   (Mexico)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Dapsone; Drug resistance; Genomic mutation; Leprosy; Mycobacterium leprae

Indexed keywords

DAPSONE; DNA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; EVALUATION; GENE; GENE MUTATION; GENETIC ASSOCIATION; GYRA GENE; HUMAN; HUMAN CELL; LEPROMATOUS LEPROSY; LEPROSY; MEXICO; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RELAPSE; RPOB GENE; SEQUENCE ANALYSIS; SKIN BIOPSY; TREATMENT OUTCOME;

BACTERIAL PROTEINS; CODON; DAPSONE; DIHYDROPTEROATE SYNTHASE; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS; MEXICO; MYCOBACTERIUM LEPRAE; POINT MUTATION; RECURRENCE; SEQUENCE ANALYSIS, DNA;

MYCOBACTERIUM LEPRAE;

EID: 38949152390     PISSN: 01874640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cambau, E., E. Perani, et al. 1997. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349(9045):103-4.
2. Dela Cruz, E., R. V. Cellona, et al. 1996. Primary dapsone resistance in Cebu, The Philippines; cause for concern. Int J Lepr Other Mycobact Dis 64(3):253-6.
3. Grosset, J. H., C. C. Guelpa-Lauras, et al. 1989. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. Int J Lepr Other Mycobact Dis 57(3):607-14.
4. Ji, B., E. G. Perani, et al. 1996. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob Agents Chemother 40(2):393-9.
5. Jocobson, R. R. and R. C. Hastings 1976. Rifampin-resistant leprosy. Lancet(4):1304-05.
6. Lockwood, D. N. (2002). Leprosy elimination-a virtual phenomenon or a reality? British Medical Journal 324(7352):1516-8.
7. Lopez Roa, R. I. and M. Fafutis Morris 2006. Leprosy in Mexico. Jpn. J. Lepr. 75:51-58.
8. Maeda, S., M. Matsuoka, et al. 2001. Multi-drug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45:3635-39.
9. Matsuoka, M., Y. Kashiwabara, et al. 2003. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy. Int J Lepr Other Mycobact Dis 71(3):240-3.
10. Matsuoka, M., Y. Kashiwabara, et al. 2000. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int J Lepr Other Mycobact Dis 68(4):452-5.
11. Matsuoka, M., L. Zhang, et al. 2004. Genotyping of Mycobacterium leprae on the basis of the polymorphism of TTC repeats for analysis of leprosy transmission. J Clin Microbiol 42(2):741-5.
12. Ozarmagan, G., M. Sutlas, et al. 2004. Detection of Dapsone Resistant Mycobacterium leprae by DNA Sequence Analysis from a Turkish Relapsed Leprosy Patient. Ist. Tip Fak. Mecmuasi 67(4):153-156.
13. Pettit, J. H. and R. J. Rees 1964. Sulphone Resistance in Leprosy. An Experimental and Clinical Study. Lancet 19:673-4.
14. Williams, D. L. and T. P. Gillis (2004). Molecular detection of drug resistance in Mycobacterium leprae. Lepr Rev 75(2):118-30.
15. Williams, D. L., T. L. Pittman, et al. 2001. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. J Clin Microbiol 39(6):2083-8.